The production of radiopharmaceuticals as compared totraditional pharmaceuticals is a multifaceted procedure and requiresspecialized facilities, equipment and operational expertise. Further, owing toits inherent hazardous nature, radiopharmaceuticals have a complex regulatorymarket authorization process. Consequently, a number of innovator companieshave demonstrated a preference for outsourcing radiopharmaceuticalmanufacturing to contract service providers.
To order this 320+page report, which features 45+ figures and 100+ tables, please visit this -https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
The USD 6+ billion (by 2030) financialopportunity associated with nuclear medicine and radiopharmaceuticalsmanufacturing, has been analyzed across the following segments:
§ Target Disease Indication
- Breast Cancer
- Chronic Lymphocytic Leukemia
- Colorectal Cancer
- Head and Neck Cancer
- Lung Cancer
- Lupus Nephritis
- Melanoma
- Multiple Myeloma
- Primary Sjögren's Syndrome
- Others
§ Target Immune Checkpoint
- B7-H3
- CD38
- CD40
- CD47
- Others
§ Mechanism of Action
- Inhibitory
- Stimulatory
§ Therapeutic Modality
- Monoclonal Antibody
- Small Molecule
§ Type of Therapy
- Monotherapy
- Combination Therapy
§ Route of Administration
- Intravenous
- Subcutaneous
- Others
§ Key Geographical Regions
- North America
- Europe
- Asia-Pacific and the Rest of the World
The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market,2020-2030 report features thefollowing companies, which we identified to be key players in this domain:
§ Advanced Accelerator Applications
§ Belgian Nuclear Research Center (SCK•CEN)
§ Cardinal Health
§ China Isotope & Radiation Corporation
§ Curium Pharma
§ DuChemBio
§ Eckert & Ziegler
§ Eczacibasi-Monrol
§ GE Healthcare
§ Jubilant DraxImage
§ Lantheus Medical Imaging
§ Nihon Medi-Physics
§ Nordion
§ PETNET Solutions
§ SinoTau Pharmaceuticals
§ SOFIE
To request for sample report - https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing/request-sample.html
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Nuclear Medicine and RadiopharmaceuticalsManufacturers (Industry Players): Current Market Landscape
5. Nuclear Medicine and Radiopharmaceuticals Manufacturers(Non-Industry Players): Current Market Landscape
6. Nuclear Medicine and Radiopharmaceuticals Manufacturers inNorth America
7. Nuclear Medicine and Radiopharmaceuticals Manufacturers inEurope
8. Nuclear Medicine and Radiopharmaceuticals Manufacturers inAsia-Pacific And Rest of The World
9. Nuclear Medicine and RadiopharmaceuticalsManufacturers: Company Competitiveness Analysis
10. Partnerships and Collaborations
11. Production and Supply Chain of Medical IsotopeMolybdenum-99 (Technetium-99m)
12. Market Forecast and Opportunity Analysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
You may also be interested in the following titles:
2. Live Biotherapeutic Products and Microbiome ContractManufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030
3. China Biopharmaceutical Contract ManufacturingMarket, 2020 - 2030
4. ContinuousManufacturing Market (Small Molecules and Biologics), 2020 – 2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
